MAPT and early-onset autosomal dominant Alzheimer disease: Clinical trials using amyloid PET, often alongside tau PET, suggest that amyloid accumulation is more prominent in Alzheimer’s disease than in CTE or TBI, reinforcing the value of tau imaging in distinguishing these conditions.